Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 1/20 | 0.39 |
| ▸ | ACACA | Q13085 | 1/20 | 0.39 |
| ▸ | DUT | P33316 | 1/20 | 0.35 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.32 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.32 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31240225 | 1.00 | ACACB (0.39) | ACACBACACADUTFFAR4FFAR1 | |
| SCHEMBL16829715 | 0.93 | FFAR4 (0.42) | ACACBACACAFFAR4FFAR1GPR84 | |
| SCHEMBL10081558 | 0.90 | FFAR1 (0.35) | ACACBACACAFFAR4FFAR1 | |
| SCHEMBL26697559 | 0.90 | FFAR4 (0.42) | ACACBACACAFFAR4FFAR1GPR84 | |
| SCHEMBL26697565 | 0.90 | FFAR4 (0.42) | ACACBACACAFFAR4FFAR1GPR84 | |
| SCHEMBL16829966 | 0.90 | FFAR4 (0.42) | ACACBACACAFFAR4FFAR1GPR84 | |
| SCHEMBL26697609 | 0.90 | FFAR4 (0.42) | ACACBACACAFFAR4FFAR1GPR84 | |
| SCHEMBL14513909 | 0.89 | USP2 (0.33) | ACACBACACADUT | |
| SCHEMBL8329760 | 0.89 | USP2 (0.33) | ACACBACACADUT | |
| SCHEMBL25242422 | 0.89 | USP2 (0.43) | ACACBACACADUT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4712948-A2 | GENE EDITING SYSTEMS AND COMPOSITIONS FOR TREATMENT OF HEMOGLOBINOPATHIES AND METHODS OF USING THE SAME | Renagade Therapeutics Management Inc. (US) | 2026-03-25 | — | — | EP | disclosed |
| WO-2024238828-A2 | GENE EDITING SYSTEMS AND COMPOSITIONS FOR TREATMENT OF HEMOGLOBINOPATHIES AND METHODS OF USING THE SAME | RENAGADE THERAPEUTICS MANAGEMENT INC. (US) | 2024-11-21 | — | — | WO | disclosed |